Add time:09/09/2019         Source:sciencedirect.com

Quinoline compounds have been extensively explored as anti-malaria and anti-cancer agents for decades and show profound functional bioactivities, however, the studies of these compounds in other medicinal fields have lagged dramatically. In this study, we report the development of a series of facilely accessible quinoline derivatives that display potent antibacterial activity against a panel of multidrug-resistant Gram-positive bacterial strains, especially C. difficile. We also demonstrated that these molecules are effective in vivo against C. difficile. These results revealed that these types of quinoline compounds could serve as prototypes for the development of an appealing class of antibiotic agents used to combat Gram-positive drug-resistant bacterial strains, including C. difficile.

We also recommend Trading Suppliers and Manufacturers of 4-CHLORO-2-METHYL-7-(TRIFLUOROMETHYL)QUINOLINE (cas 18529-09-4). Pls Click Website Link as below: cas 18529-09-4 suppliers